v3.26.1
Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Common Stock Equivalents (Details) - shares
3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]        
Total common stock equivalents excluded from dilutive loss per share 762,457   775,790 1,586,624
Total common stock equivalents included in dilutive income per share   21,801    
HBC Earnout Shares [Member]        
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]        
Total common stock equivalents excluded from dilutive loss per share 4,000     450,000
Warrants – Public [Member]        
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]        
Total common stock equivalents excluded from dilutive loss per share 123,500   123,500 123,500
Warrants - Private [Member]        
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]        
Total common stock equivalents excluded from dilutive loss per share 108,100   108,100 108,100
Warrants - Series A [Member]        
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]        
Total common stock equivalents excluded from dilutive loss per share 508,857   508,857 167,976
Stock-based compensation - equity awards [Member]        
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]        
Total common stock equivalents excluded from dilutive loss per share 6,000   19,333  
Stock-based compensation - warrants [Member]        
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]        
Total common stock equivalents excluded from dilutive loss per share 12,000   12,000  
Stock-based compensation - equity awards [Member]        
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]        
Total common stock equivalents included in dilutive income per share   21,801